The Antiaggregation Monitoring (TAM) Registry

计划入组 200 人 · 首次发布于 2011 年 4 月 5 日

The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)

计划入组 680 人 · 首次发布于 2005 年 9 月 9 日

Efficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast Cancer

计划入组 120 人 · 首次发布于 2021 年 5 月 18 日

TAM-02

TAM-163

TAM-03

TAS

TAC

Canada

Pharma VAM

TAM Global Appoints Leading Cancer Immunologist Dr. Francesco Marincola as Chief Scientific Officer

FDA and EMA Grant Orphan Drug Designation to CPI-008 for Pancreatic Cancer Surgical Imaging

Roche Partner MediLink's B7-H3 ADC Tam-Peli Cuts Death Risk 54% in Relapsed SCLC Phase III